VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the 28th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2010 at 1:30 PM (PST) at the Westin St. Francis in San Francisco, California.
